Cerubidine

Active Ingredient(s): Daunorubicin
FDA Approved: * December 19, 1979
Pharm Company: * WYETH AYERST
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cerubidine Overview

Daunorubicin, also known as daunomycin, is a chemotherapy medication used to treat cancer.[1] Specifically it is used for acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma.[1] It is used by injection into a vein.[1] A liposomal formulation known as liposomal daunorubicin also exists.[1] Common side effects include hair loss, vomiting, bone marrow suppression, ...

Read more Cerubidine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Daunorubicin

Recent Cerubidine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Daunorubicin or a similar ingredient: (5 results)

• DAUNORUBICIN
• DAUNORUBICIN + CYTARABINE
• DAUNORUBICIN LIPOSOMAL
• DAUNOXOME Daunorubicin Liposomal
• VYXEOS Daunorubicin + Cytarabine